Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bar

Showing results (491-500 of 540) with videos related to

Pageof 54
Sort By:
Vaccine|September 7, 2023
Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1-uninfected adult participants in the USHong-Van Tieu, Shelly Karuna, Yunda Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2020
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancerR Perets, J Bar, D W Rasco, et al.
Cell Reports. Medicine|November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyJonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
Nature Immunology|December 19, 2022
Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4<sup>+</sup> T cell reservoirVincent H Wu, Jayme M L Nordin, Son Nguyen, et al.
Epidemics|July 4, 2024
Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaquesEllie Mainou, Stella J Berendam, Veronica Obregon-Perko, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Assessing the impact of autologous neutralizing antibodies on rebound dynamics in postnatally SHIV-infected ART-treated infant rhesus macaquesEllie Mainou, Stella J Berendam, Veronica Obregon-Perko, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Comparative analysis of within-host dynamics of acute infection and viral rebound dynamics in postnatally SHIV-infected ART-treated infant rhesus macaquesEllie Mainou, Stella J Berendam, Veronica Obregon-Perko, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Assessing the impact of autologous neutralizing antibodies on viral rebound in postnatally SHIV-infected ART-treated infant rhesus macaquesEllie Mainou, Stella J Berendam, Veronica Obregon-Perko, et al.
Journal of Virology|June 21, 2019
Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal ImmunopathologyKatharine J Bar, Ernesto Coronado, Tiffany Hensley-McBain, et al.
Journal of Virology|July 15, 2016
Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal InfectionMichael J Lopker, Gregory Q Del Prete, Jacob D Estes, et al.
Pageof 54

Showing results (491-500 of 540) with videos related to

Sort By:
Pageof 54
Vaccine|September 7, 2023
Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1-uninfected adult participants in the USHong-Van Tieu, Shelly Karuna, Yunda Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2020
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancerR Perets, J Bar, D W Rasco, et al.
Cell Reports. Medicine|November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyJonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
Nature Immunology|December 19, 2022
Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4<sup>+</sup> T cell reservoirVincent H Wu, Jayme M L Nordin, Son Nguyen, et al.
Epidemics|July 4, 2024
Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaquesEllie Mainou, Stella J Berendam, Veronica Obregon-Perko, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Assessing the impact of autologous neutralizing antibodies on rebound dynamics in postnatally SHIV-infected ART-treated infant rhesus macaquesEllie Mainou, Stella J Berendam, Veronica Obregon-Perko, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Comparative analysis of within-host dynamics of acute infection and viral rebound dynamics in postnatally SHIV-infected ART-treated infant rhesus macaquesEllie Mainou, Stella J Berendam, Veronica Obregon-Perko, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Assessing the impact of autologous neutralizing antibodies on viral rebound in postnatally SHIV-infected ART-treated infant rhesus macaquesEllie Mainou, Stella J Berendam, Veronica Obregon-Perko, et al.
Journal of Virology|June 21, 2019
Simian-Human Immunodeficiency Virus SHIV.CH505 Infection of Rhesus Macaques Results in Persistent Viral Replication and Induces Intestinal ImmunopathologyKatharine J Bar, Ernesto Coronado, Tiffany Hensley-McBain, et al.
Journal of Virology|July 15, 2016
Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal InfectionMichael J Lopker, Gregory Q Del Prete, Jacob D Estes, et al.
Pageof 54